pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›iron
drug
save

iron

updated 6mo ago
by Sri Devaraj Urs Academy of Higher Education and Research
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval56 co-mentions · 29 sources
  • drugsuccharated ferric oxide33 co-mentions · 30 sources
  • drugIRON SUCROSE33 co-mentions · 30 sources
  • tagRecall10 co-mentions · 6 sources
  • companyAmerican Regent Inc8 co-mentions · 3 sources
  • drugRNS-604 co-mentions · 2 sources
  • company$FMSFresenius Medical Care AG4 co-mentions · 2 sources
  • company$FMCQFFresenius Medical Care AG4 co-mentions · 2 sources

all catalysts(1)

phase 2 initiation · 1
Apr 24, 2026
phase 2 initiation
7mo ago
Sri Devaraj Urs Academy of Higher Education and Research — iron (Phase II Trial Initiation)
iron
→

Trials studying iron

  • phase2Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumorsrecruitingn=370
  • N/ADecoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Diseaserecruitingn=5
  • —Bioneer Q-RFIA Clinical Evaluationrecruitingn=2,350
  • phase2Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumorsrecruitingn=534
  • phase4Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Womenrecruitingn=146
  • phase4Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failureterminatedn=6
  • N/AHypoferritinemia Without Anemia Among Reproductive Age Femalescompletedn=300
  • EP1A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.not yet recruitingn=72

News(10)

  • Marrow sets out to challenge genetic medicines for severe blood diseases
    Armed with $173 million in venture funding, the startup is developing what it’s positioning as a more accessible alternative to gene therapy and gene editing treatments for sickle cell and beta tha…
    biopharma_dive · 16h ago
  • STAT+: As more doctors consult chatbots, health systems can block them — or buy in
    As hundreds of thousands of doctors consult AI chatbots to make care decisions, health systems see new risks to patients' health data.
    stat · 12d ago
  • Top health takeaways from the midterm elections
    Democrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health takeaways from the midterms.
    stat · 13d ago
  • STAT+: Amid Mass General Brigham layoffs, CEO pens vague letter, stirring staff anxiety
    A cryptic email sent to Mass General Brigham employees by the health system's CEO is stirring staff anxiety less than two weeks after a round of layoffs.
    stat · 14d ago
  • Opinion: Health care needs buyers willing to say no
    "The industry’s major players have little appetite for change," writes Anthony T. Lo Sasso.
    stat · 19d ago
  • Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry
    As costs surge, voters are embracing more radical solutions to the crisis.
    stat · 19d ago
  • What has actually caused the decline in drug overdose deaths?
    After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary data from 2025 show another meaningful drop.
    stat · 20d ago
  • STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
    A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation.
    stat · 20d ago
  • Have you been impacted by Epic’s actions?
    STAT is looking to learn, from people with direct knowledge, how Epic's actions impact hospitals' technology choices. Share your story with us.
    stat · 20d ago
  • The 4 stages of women’s heart health: New framework for doctors and patients
    New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health.
    stat · 22d ago
view all news mentions →
Data sources
ClinicalTrials.gov
last refreshed 44m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?